Based on the Surgical Science Sweden AB stock forecast from 0 analysts, the average analyst target price for Surgical Science Sweden AB is not available over the next 12 months. Surgical Science Sweden AB’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Surgical Science Sweden AB is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, Surgical Science Sweden AB’s stock price was SEK 150.28. Surgical Science Sweden AB’s stock price has changed by +1.32% over the past week, -7.39% over the past month and +7.52% over the last year.
No recent analyst target price found for Surgical Science Sweden AB
No recent average analyst rating found for Surgical Science Sweden AB
Company Overview Surgical Science Sweden AB
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based medical training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; LAP Mentor simulator provides laparoscopic training; and LapSim essence, a portable and ready-to-use VR laparoscopic simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; GI Mentor, the gold standard simulator for the training of gastrointestinal upper and lower endoscopic procedures; Ultrasound Mentor, a cross-specialty solution for ultrasound training; Angio Mentor simulator provides endovascular training; Spine Mentor, a virtual reality training simulator for minimal invasive spine surgery; GI-BRONCH Mentor platform that offers a combined system for GI endoscopy and flexible bronchoscopy training; Perc Mentor simulator provides ultrasound and fluoroscopy training; ARTHRO Mentor, an advanced arthroscopic training simulator; PELVIC Mentor simulator provides anatomy and pelvic exam training; URO Mentor, a virtual reality simulator for endourology training; simbionix simulators; and robotic surgery simulators. Surgical Science AB was incorporated in 1997 and is headquartered in Gothenburg, Sweden. Address: Drakegatan 7 A, 3 tr., Gothenburg, Sweden, 412 50 Read Less
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based medical training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; LAP Mentor simulator provides laparo...Read More
Frequently Asked Questions About Surgical Science Sweden AB (0AAU:LSE) Stock
Stock Target Advisor's fundamental analysis for Surgical Science Sweden AB's stock is Neutral.
Unfortunately we do not have enough data on 0AAU:LSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 0AAU:LSE's stock to indicate what its average analyst target is.
0AAU:LSE stock's Price/Earning ratio is 0.71.
Based on this 0AAU:LSE may be a overvalued for its sector.
The last closing price of 0AAU:LSE's stock was SEK 150.28.
Unfortunately we do not currently have any market capitalization data for 0AAU:LSE's stock.
Unfortunately we do not have enough analyst data on 0AAU:LSE's stock to indicate whether its price will go up or not.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0AAU:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
